Sorafenib, a multikinase inhibitor, is effective in vitro against non‐hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin
暂无分享,去创建一个
S. Vincent Rajkumar | Shaji K. Kumar | A. Adjei | V. Ramakrishnan | T. Witzig | T. Kimlinger | M. Timm | J. Haug | L. Wellik | T. Halling